Skip to main content

Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population".

Publication ,  Journal Article
Wittbrodt, ET; Eudicone, JM; Bell, KF; Enhoffer, DM; Latham, K; Green, JB
Published in: Am J Manag Care
April 2019

The authors of the manuscript "Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population" respond to a letter to the editor.

Duke Scholars

Published In

Am J Manag Care

EISSN

1936-2692

Publication Date

April 2019

Volume

25

Issue

4

Start / End Page

171 / 172

Location

United States

Related Subject Headings

  • Humans
  • Health Policy & Services
  • Glucagon-Like Peptide-1 Receptor
  • Glucagon-Like Peptide 1
  • Diabetes Mellitus, Type 2
  • 4203 Health services and systems
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wittbrodt, E. T., Eudicone, J. M., Bell, K. F., Enhoffer, D. M., Latham, K., & Green, J. B. (2019). Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population". Am J Manag Care, 25(4), 171–172.
Wittbrodt, Eric T., James M. Eudicone, Kelly F. Bell, Devin M. Enhoffer, Keith Latham, and Jennifer B. Green. “Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population".Am J Manag Care 25, no. 4 (April 2019): 171–72.
Wittbrodt ET, Eudicone JM, Bell KF, Enhoffer DM, Latham K, Green JB. Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population". Am J Manag Care. 2019 Apr;25(4):171–2.
Wittbrodt, Eric T., et al. “Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population".Am J Manag Care, vol. 25, no. 4, Apr. 2019, pp. 171–72.
Wittbrodt ET, Eudicone JM, Bell KF, Enhoffer DM, Latham K, Green JB. Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population". Am J Manag Care. 2019 Apr;25(4):171–172.

Published In

Am J Manag Care

EISSN

1936-2692

Publication Date

April 2019

Volume

25

Issue

4

Start / End Page

171 / 172

Location

United States

Related Subject Headings

  • Humans
  • Health Policy & Services
  • Glucagon-Like Peptide-1 Receptor
  • Glucagon-Like Peptide 1
  • Diabetes Mellitus, Type 2
  • 4203 Health services and systems
  • 1117 Public Health and Health Services